Search research articles
Contact Us
Filters
Showing results (191-200 of 202) with videos related to
Page
of 21
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
July 29, 2016
Intratumoral genetic heterogeneity and number of cytogenetic aberrations provide additional prognostic significance in chronic lymphocytic leukemia
Shuhua Yi, Zengjun Li, Dehui Zou, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 8, 2018
Tolerance, Kinetics, and Depth of Response for Subcutaneous Versus Intravenous Administration of Bortezomib Combination in Chinese Patients With Newly Diagnosed Multiple Myeloma
Yan Xu, Shuhui Deng, Xuehan Mao, et al.
Clinical & Translational Immunology
|
January 30, 2020
Prominent immune signatures of T cells are specifically associated with indolent B-cell lymphoproliferative disorders and predict prognosis
Shuhua Yi, Yu Zhang, Wenjie Xiong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2024
Identification of Therapy-Induced Clonal Evolution and Resistance Pathways in Minimal Residual Clones in Multiple Myeloma through Single-Cell Sequencing
Jian Cui, Xiaoyun Li, Shuhui Deng, et al.
Blood Advances
|
October 10, 2019
The impact of response kinetics for multiple myeloma in the era of novel agents
Yuting Yan, Xuehan Mao, Jiahui Liu, et al.
Nanoscale
|
February 9, 2016
Visual and efficient immunosensor technique for advancing biomedical applications of quantum dots on Salmonella detection and isolation
Feng Tang, Dai-Wen Pang, Zhi Chen, et al.
Journal of Hematology & Oncology
|
September 7, 2020
Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
Runxia Gu, Fang Liu, Dehui Zou, et al.
Journal for Immunotherapy of Cancer
|
April 17, 2024
Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma
Wei Liu, Wei Liu, Hesong Zou, et al.
Leukemia
|
October 9, 2019
Monitoring the cytogenetic architecture of minimal residual plasma cells indicates therapy-induced clonal selection in multiple myeloma
Gang An, Yuting Yan, Yan Xu, et al.
Blood Advances
|
March 6, 2019
Secretory status of monoclonal immunoglobulin is related to the outcome of patients with myeloma: a retrospective study
Xiao-Qi Qin, Gang An, Zeng-Jun Li, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 202) with videos related to
Sort By:
Page
of 21
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
July 29, 2016
Intratumoral genetic heterogeneity and number of cytogenetic aberrations provide additional prognostic significance in chronic lymphocytic leukemia
Shuhua Yi, Zengjun Li, Dehui Zou, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 8, 2018
Tolerance, Kinetics, and Depth of Response for Subcutaneous Versus Intravenous Administration of Bortezomib Combination in Chinese Patients With Newly Diagnosed Multiple Myeloma
Yan Xu, Shuhui Deng, Xuehan Mao, et al.
Clinical & Translational Immunology
|
January 30, 2020
Prominent immune signatures of T cells are specifically associated with indolent B-cell lymphoproliferative disorders and predict prognosis
Shuhua Yi, Yu Zhang, Wenjie Xiong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2024
Identification of Therapy-Induced Clonal Evolution and Resistance Pathways in Minimal Residual Clones in Multiple Myeloma through Single-Cell Sequencing
Jian Cui, Xiaoyun Li, Shuhui Deng, et al.
Blood Advances
|
October 10, 2019
The impact of response kinetics for multiple myeloma in the era of novel agents
Yuting Yan, Xuehan Mao, Jiahui Liu, et al.
Nanoscale
|
February 9, 2016
Visual and efficient immunosensor technique for advancing biomedical applications of quantum dots on Salmonella detection and isolation
Feng Tang, Dai-Wen Pang, Zhi Chen, et al.
Journal of Hematology & Oncology
|
September 7, 2020
Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
Runxia Gu, Fang Liu, Dehui Zou, et al.
Journal for Immunotherapy of Cancer
|
April 17, 2024
Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma
Wei Liu, Wei Liu, Hesong Zou, et al.
Leukemia
|
October 9, 2019
Monitoring the cytogenetic architecture of minimal residual plasma cells indicates therapy-induced clonal selection in multiple myeloma
Gang An, Yuting Yan, Yan Xu, et al.
Blood Advances
|
March 6, 2019
Secretory status of monoclonal immunoglobulin is related to the outcome of patients with myeloma: a retrospective study
Xiao-Qi Qin, Gang An, Zeng-Jun Li, et al.
Page
of 21